-
Mashup Score: 1Disclose or not disclose – COIs mismanagement erodes public trust - ESMO Perspectives - 1 year(s) ago
There is a broader negligence of the public health consequences of individual actions among the health providers
Source: perspectives.esmo.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1You are not your COI, but COI can make you - ESMO Perspectives - 2 year(s) ago
There is a misunderstanding in what financial conflict of interests do on single people and what system implications they may have
Source: perspectives.esmo.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Artificial Intelligence: a ‘smart’ arrow in our quiver against cancer - ESMO Perspectives - 2 year(s) ago
Many studies presented at ESMO Congress 2022 show the potential of artificial intelligence to enhance personalised oncology
Source: perspectives.esmo.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 5
The new FDA guidance could be an important step toward necessary change to give adequate representation of older adults in cancer clinical trials
Source: perspectives.esmo.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 3Colorectal cancer: guided by the gut? - ESMO Perspectives - 2 year(s) ago
Recent evidence suggests a role of the microbiome in cancer pathogenesis and as a potential therapeutic target, but it is still early days
Source: perspectives.esmo.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0De-escalation of cancer treatments may be key to sustainability in oncology - ESMO Perspectives - 2 year(s) ago
Treating patients at reduced doses could contribute to a more efficient allocation of healthcare resources and improve access to costly treatments aroun…
Source: perspectives.esmo.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Cancer treatment – how to wisely reduce its burden? A new ESMO tool to guide de-intensification - ESMO Perspectives - 2 year(s) ago
ESMO developed a classification to assess the risk-benefit ratio of treatment intensity modulation by a three-tiered approach
Source: perspectives.esmo.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 9
Experience in breast cancer shows that treatment de-intensification must follow robust evidence, but also values and preferences to generate acceptance
Source: perspectives.esmo.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 3
In recent conflicts, good response to the health needs of refugees with cancer in receiving countries is consequence of an analysis of local cancer cent…
Source: perspectives.esmo.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
The new FDA guidance could be an important step toward necessary change to give adequate representation of older adults in cancer clinical trials
Source: perspectives.esmo.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
Disclose or not disclose – COIs mismanagement erodes public trust. Learn more on the many controversial aspects of this topic wt, @darioT_ , on #ESMOPerspectives 👉https://t.co/NpLD5jOvyP https://t.co/zojWzrG3be